Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report
Article in Frontiers in Immunology (March 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (March 2024)
Article in Frontiers in Oncology (June 2022)
Article in Health Science Reports (March 2022)